The study assessed the safety and efficacy of intra-articular NASHA treatment compared to control saline injections, other hyaluronic acid products and other injectables including corticosteroids, platelet-rich plasma and mesenchymal stem cells in patients with knee osteoarthritis.
Patients reported sustained relief of knee osteoarthritis symptoms following a single NASHA injection. The researchers also observed a low incidence of treatment-related adverse events.
More articles on biologics:
Who are the 14 major players in the global spine biologics market?
Cerapedics i-FACTOR yields 50% fusion rate vs. 20% for allograft at 1-year follow-up — 3 insights
3 things to know about Burst Biologics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
